TOP特許意匠商標
商標ウォッチ Twitter
公開日2025-05-21
公報種別公開国際商標公報
国際登録番号1844954
国際登録日2024-12-27
区分第5類(薬剤),第30類(加工食品)
商品役務Dietetic foods adapted for medical purposes; dietetic beverages adapted for medical purposes; dietetic substances adapted for medical use; nutritional supplements; nutraceutical preparations for therapeutic or medical purposes; pharmaceutical preparations; phytotherapy preparations for medical purposes; dietary supplements for animals; medicinal plant extracts, other than essential oils; medicinal herbal extracts, other than essential oils, for medical purposes.,Coffee; coffee-based beverages; tea; herbal teas; tea-based beverages; sugar; rice-based snack food; fondants [confectionery]; cereal-based snack food; flour.
基礎出願番号82008060
基礎出願日2024-11-16
基礎出願国CN
出願人Fuco (Shanghai) Biotech Co., Ltd.
OCRテキストONCOFUCO
OCRテキスト2ONCOFUCO
OCRについて
この商標をJ-PlatPatで参照する

関連商標

Huang, Ke
26日前
Aston Group Worldwide Ltd
INESSA
1か月前
Biohaven Therapeutics Ltd.
2か月前
NUTRITIONAL WHOLESOME BLENDS PTY LTD
Blended. BYSARAH
2か月前
Biohaven Therapeutics Ltd.
REJUTRIA
2か月前
Huang, Ke
26日前
Made By Brave Limited
ANCIENT+BRAVE
1か月前
MAFRA GROUP S.r.l.
MANIAC LINE
1か月前
Harbin Fuerjia Technology Co., Ltd.
Voolga
1か月前
BEIJING INNO MEDICINE CO., LTD.
2か月前
Zero21 Holdings Limited
A-GAME
2か月前
CELLTRION, INC.
2か月前
Incyte Holdings Corporation
QPARIKO
2か月前
ADM Protexin Limited
2か月前
BeiGene Switzerland GmbH
2か月前
BEIJING INNO MEDICINE CO., LTD.
2か月前
NOVARTIS AG
4か月前
Shanghai Bao Pharmaceuticals Co.,Ltd.
2か月前
RecoVet GmbH
1か月前
NUTRASOURCE PHARMACEUTICAL AND NUTRACEUTICAL SERVICES INC.
2か月前
KOREATECH Co., Ltd.
2か月前
JION MEDITECH Co. Ltd
2か月前
Amorepacific Corporation
2か月前
Amorepacific Corporation
2か月前
Amorepacific Corporation
2か月前
NUTRASOURCE PHARMACEUTICAL AND NUTRACEUTICAL SERVICES INC.
2か月前
PROVEPHARM LIFE SOLUTIONS
2か月前
AstraZeneca AB
2か月前
EXELTIS HEALTHCARE, S.L.
2か月前
Cascade Pharmaceuticals, Inc
2か月前
Alvotech hf.
1か月前
RecoVet GmbH
1か月前
個人
1か月前
F. Hoffmann-La Roche AG
LIFSTUVA
29日前
Vir Biotechnology, Inc.
VirBiotechnology
29日前
Vir Biotechnology, Inc.
29日前
続きを見る